A Psychonaut's Experience of Intoxication with Multiple Classes of Drugs Including Novel Psychoactive Substance 2-fluorodeschloroketamine: Case Report and Urinary Analysis.
Kristina Domanski, Steven W Fleming, Hayden Maag, Emily Bouso Raley, Joshua Debord, Brooks Wright, Roya Mahana
Journal of Psychoactive Drugs 2022 DOI: 10.1080/02791072.2021.2006373 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | A 28-year-old man with polysubstance use |
| Intervention | supportive care |
| Topics | Ketamine |
| Keywords | 2-fluorodeschloroketamine Novel psychoactive substances |
| Citations | 7 |
| Key findings | 2-FDCK, a novel psychoactive substance, was confirmed in a patient's urine after insufflation, marking the first reported case in the United States and underscoring its easy online availability and abuse potential. |
Abstract
Novel psychoactive substances have emerged as drugs of abuse. 2-Fluorodeschloroketamine (2-FDCK) is a ketamine derivative that can be purchased online for as little as $12 per gram. We report the case of a patient with a history of polysubstance use presenting after insufflation of 2-FDCK, with subsequent confirmation of metabolites in the patient's urine. A 28-year-old man presented to the Emergency Department in a dissociated state. He recovered well with supportive care, and described during interview his experience of substance use including the novel psychoactive substance 2-FDCK. A urine sample was sent for analysis and 2-FDCK metabolites were isolated. This case is concerning because 2-FDCK is a relatively new agent that has not yet been reported in the United States. It is easy to obtain over the internet and has significant abuse potential.